DANIEL K SPIEGELMAN Insider Trading $MYGN MYRIAD GENETICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL K SPIEGELMAN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL K SPIEGELMAN. DANIEL K SPIEGELMAN is Senior Vice President and CFO in CV THERAPEUTICS INC ($CVTX) and Director in MYRIAD GENETICS INC ($MYGN) and EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in Oncothyreon Inc. ($ONTY) and Director in Relypsa Inc ($RLYP).

DANIEL K SPIEGELMAN in MYRIAD GENETICS INC

Trading Symbol: MYGN
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 20,562 shares
Current Value: $316,655
Latest Transaction: May 28 2021
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL K SPIEGELMAN in MYRIAD GENETICS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BMRN, CASC, CVTX, MYGN, RLYP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Shares	Total Shares	% Holdings
May 28 2021	MYGN	MYRIAD GENETICS IN ...	SPIEGELMAN DANIEL K	Director	Sell	D	15,889	20,562	36.5 K to 20.6 K (-43.59 %)
Dec 07 2020	MYGN	MYRIAD GENETICS IN ...	SPIEGELMAN DANIEL K	Director	Grant	A	15,889	36,451	20.6 K to 36.5 K (+77.27 %)
May 28 2020	MYGN	MYRIAD GENETICS IN ...	SPIEGELMAN DANIEL K	Director	Grant	A	20,562	20,562	0 to 20.6 K

Page: 1